drugset / Trial / NCT01392014

Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Cases

NCT01392014 ↗

Phase 4 Completed 374 enrolled Indonesia University
RandomizedParallel-groupOpen-labelPrevention

Summary

Artemisinin-based combination therapy (ACT) has been known to be controversial for stopping malaria transmission.The addition of primaquine (PQ) - the only drug commercially available that kills mature transmission stage - to such treatments might be necessary to eliminate this stage. A study is conducted to evaluate the efficacy of dihydroartemisinin-piperaquine (DHP) regimens with or without PQ on the sexual and asexual stages of P. falciparum in Sumatra, Indonesia.

Timeline

Start
2008-12
Primary completion
2010-03
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator ARTENIMOL Small molecule 40 mg —
Comparator ARTENIMOL Small molecule 60 mg —
Comparator ARTENIMOL Small molecule 80 mg —
Comparator ARTENIMOL Small molecule 120 mg —
Comparator Primaquine Small molecule 0.75 mg/kg —
Comparator piperaquine Small molecule 320 mg —
Comparator piperaquine Small molecule 480 mg —
Comparator piperaquine Small molecule 640 mg —
Comparator piperaquine Small molecule 960 mg —